Condition category
Cancer
Date applied
19/08/2002
Date assigned
19/08/2002
Last edited
03/01/2012
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr - -

ORCID ID

Contact details

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

NCT00867347

Protocol/serial number

ICR/PELVIC

Study information

Scientific title

Acronym

Study hypothesis

Not provided at time of registration

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Treatment

Patient information sheet

Condition

Cancer: Bladder (advanced), Bladder (superficial), Multiple Sites, Prostate, Rectum

Intervention

1. Group A: Conventional radiotherapy using a three field technique employing rectangular fields. Suggested dosage, 64 Gy in 2 Gy fractions five times a week
2. Group B: Conformal radiotherapy using a three field technique employing fields shaped with customised blocks drawn according to the beam's-eye view of the target volume. Suggested dosage, 64 Gy in 2 Gy fractions five times a week.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/01/2001

Overall trial end date

31/12/2001

Reason abandoned

Eligibility

Participant inclusion criteria

1. Carcinoma of the pelvic region (eg prostate, bladder, rectum, etc)
2. Patients scheduled to undergo pelvic radiotherapy by a CT planned technique with less than four fields provided a satisfactory localisation on the simulator can be achieved

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/01/2001

Recruitment end date

31/12/2001

Locations

Countries of recruitment

United Kingdom

Trial participating centre

UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom

Sponsor information

Organisation

The Institute of Cancer Research (UK)

Sponsor details

123 Old Brompton Road
London
SW7 3RP
United Kingdom

Sponsor type

Government

Website

http://www.icr.ac.uk

Funders

Funder type

Research organisation

Funder name

Institute of Cancer Research (UK)

Alternative name(s)

l'Institut du cancer, Institut du Cancer, ICR

Funding Body Type

government organisation

Funding Body Subtype

Federal/National Government

Location

Canada

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1997 results in http://www.ncbi.nlm.nih.gov/pubmed/9106921

Publication citations

  1. Results

    Tait DM, Nahum AE, Meyer LC, Law M, Dearnaley DP, Horwich A, Mayles WP, Yarnold JR, Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment., Radiother Oncol, 1997, 42, 2, 121-136.

Additional files

Editorial Notes